NCT06804135View on ClinicalTrials.gov

Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

110

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2030

Conditions

Cervical Carcinoma

All Listed Sponsors

lead

Tata Memorial Hospital

OTHER_GOV

NCT06804135 - Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer | Biotech Hunter | Biotech Hunter